Lyra Therapeutics raises $29.5M for chronic rhinosinusitis drug implant
The company plans to use the funding to advance LYR-210 into a Phase II clinical trial and also explore its development platform in other ENT diseases.
Orchard Therapeutics closes $150 million Series C round
The oversubscribed round comes just four months after acquisition of GSK's gene therapy portfolio.
The Power Behind Enterprise EHR Software for Large Healthcare Systems
Enterprise EHR boosts scalability, interoperability, and governance for large healthcare systems.